The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta‐analysis

OUP accepted manuscript

(2018)   JNCI-Journal of the National Cancer Institute

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death

(2017) Rong Na et al.   EUROPEAN UROLOGY

Germline BRCA mutation in male carriers—ripe for precision oncology?

(2017) Ricardo Romão Nazário Leão et al.   PROSTATE CANCER AND PROSTATIC DISEASES

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017

(2016) Mary B. Daly et al.   Journal of the National Comprehensive Cancer Network

Prostate cancer

(2016) Gerhardt Attard et al.   LANCET

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

(2016) Colin C. Pritchard et al.   NEW ENGLAND JOURNAL OF MEDICINE

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA

(2016) Kasmintan A. Schrader et al.   JAMA Oncology

Altered significance of D'Amico risk classification in patients with prostate cancer linked to a familial breast cancer (kConFab) cohort

(2015) Damien Bolton et al.   BJU INTERNATIONAL

Integrative Clinical Genomics of Advanced Prostate Cancer

(2015) Dan Robinson et al.   CELL

Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer

(2015) Elena Castro et al.   EUROPEAN UROLOGY

The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer

(2015) Sofia Maia et al.   Familial Cancer

Overexpression of BRCA1 or BRCA2 in prostatectomy specimens is predictive of biochemical recurrence after radical prostatectomy

(2015) Sung Han Kim et al.   HISTOPATHOLOGY

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

(2015) Joaquin Mateo et al.   NEW ENGLAND JOURNAL OF MEDICINE

The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer

(2014) M R Akbari et al.   BRITISH JOURNAL OF CANCER

Cancers associated withBRCA1andBRCA2mutations other than breast and ovarian

(2014) Jacqueline Mersch et al.   CANCER

Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

(2014) Elizabeth K. Bancroft et al.   EUROPEAN UROLOGY

Subgroups of familial and aggressive prostate cancer with considerable frequencies ofBRCA2mutations

(2014) Christiane Maier et al.   PROSTATE

GermlineBRCAMutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer

(2013) Elena Castro et al.   JOURNAL OF CLINICAL ONCOLOGY

An inherited NBN mutation is associated with poor prognosis prostate cancer

(2012) C Cybulski et al.   BRITISH JOURNAL OF CANCER

Germline BRCA1 mutations increase prostate cancer risk

(2012) D Leongamornlert et al.   BRITISH JOURNAL OF CANCER

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

(2011) Z Kote-Jarai et al.   BRITISH JOURNAL OF CANCER

Decreased Prostate Cancer-Specific Survival of Men withBRCA2 Mutations from Multiple Breast Cancer Families

(2011) Heather Thorne et al.   Cancer Prevention Research

Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations

(2011) A. Moran et al.   Familial Cancer

BRCA1 mutations do not increase prostate cancer risk: Results from a meta-analysis including new data

(2011) Laura Fachal et al.   PROSTATE

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis

(2010) S M Edwards et al.   BRITISH JOURNAL OF CANCER

Germline mutations of BRCA1 and BRCA2 genes in Turkish breast, ovarian, and prostate cancer patients

(2010) Esra Manguoğlu et al.   CANCER GENETICS AND CYTOGENETICS

Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer

(2010) D. J. Gallagher et al.   CLINICAL CANCER RESEARCH

Associations of High-Grade Prostate Cancer with BRCA1 and BRCA2 Founder Mutations

(2009) I. Agalliu et al.   CLINICAL CANCER RESEARCH

BRCA1 mutations and prostate cancer in Poland

(2009) Cezary Cybulski et al.   EUROPEAN JOURNAL OF CANCER PREVENTION